Neuroendocrine adenoma of the middle ear (NAME) is a rare tumor. We report a case of NAME, the clinical and pathologic findings of which illustrate the biologic behavior of adenomatous tumors of the middle ear and their relationship with rare carcinoid tumors of the middle ear. A 29-year-old man presented with a history of recurrent otitis media, right conductive hearing loss, and auralfullness. The tumor wasremovedin itsentirety. Otolaryngologists should be familiar with this unusual but important entity.
Introduction
Neuroe ndocrine adeno ma of the middle ear (NAME) is the latest label of many that have been appli ed to a distin ctive, rare tumor of th e middle ear since its earliest published menti on by Treitel in 1898.' Until recently, controversy over its histol ogic origin and debate con cerning its appropriate designation have led to inappropriate diagnosis of this lesion as ceruminoma, ceruminous adenocarcinoma, ectopic salivary gland tumor, adenocarcinoma, and oth er entities. Derlacki and Barn ey in 1976 described the tumor as adenomatous to account for its glandular appearance but atypical biologic behavior,' and fur ther studies have appre ciated its neuroendocrine differenti ation .?" Th e clinical and pat hologic findin gs in our patient illustrate the biologicbehavior ofadenoma tous tumors of the middle ear and th eir relation ship with rare carcino id tumors of the middle ear. From 
Case report
A 29-year-old .elementary school music teacher with a history of six to seven episodes of otiti s media over th e pr evious 2 years present ed with right conductive hearin g loss and aural fullness th at had pro gressed over th e precedin g year. Until 2 years earlier, he had never exper ienced any difficulti es with his ears. He had undergone tymp ano stomy tub e placement for recurrent otitis media shor tly before he was refer red to our clinic, at which time a m idd le ear mass was observed and biopsied. Path ology was thought to be consistent with a ceru mino us adeno ma . He denied true vertigo, altho ugh he had experienced occasional disequilibrium during th e previou s few years. He denied otorr hea, tinnitus, and otalgia. Examination of th e patient's tymp anic membrane revealed a myringotomy incision on th e right with a whit e, fleshy mass protruding th rough the opening, which appeared to be contiguous with a mass seen th rough the posterior half of the tympanic membrane. The mass partiall y obscured complete evaluation and assessment of the malleus.
A compute d tomography (CT) scan was obt ained, revealing a soft-tissue den sity adjacent to the promon tory (figure 1). It filled th e sinus tympani and was adjacent to th e pyramidal em inence. Th e mass was directly adjacent to th e round window an d filled th e oval window. No definit e signs oferosio n of the ossicles were visible, altho ugh th e mass surrounded th e incus, part of the malleus, and extended int o Prussak's space without ero ding th e scutum . The mass pr ojected into th e epitympanum but did not persist at th e level of th e aditus ad antru m .
Th e patient underwent a tymp anom astoidectomy.Facial nerve electromyographywas perform ed throughout th e procedure, and there was no evidence of facial ner ve injury or malfunction . Tymp anom eatal flap elevation afforded adequate access to th e middle ear. The ear canal was intact and not involved with the tumor. The ma ss was encountered low in th e hypot ympanum, fillin g th e sinus tympani . Its location and th e patient's age rendered th ediagn osis ofceru min ous adeno ma unlikely, and protein express ion con firmed th at th e mass was a NAME tumor.
Th e tumor was dissected easily fro m the sinu s tympani. However, it was firml y attached to the tympanic membrane at the level of the umbo, requiring resection of th e po rti on_of the tympanic membran e that was in contact with the tumor. Firm tissue below th e stapes passed through th e obturator for am en and could not be dissected easily. Th erefore, total stapedecto my was perform ed. Tumor involveme nt of Jacobson's can al required division of th e Jacobson 's nerve. Th e mass did not extend into th e attic, nor did th ere appear to be promontorybone involvement. The tumor was remo ved in its entirety.
Sampl es were taken from distinct regions of the tumor and prepared as frozen sectio ns. Th e specimens were describ ed grossly as irreg ular, pinkish or brownish-tan soft-tissue fragme nts. Fibrous tissue sam ples from th e stapes margin con sisted of cells with small, hyperchrom atic nucl ei and mildly to moderately pink cytoplasm. Cells from th e middle ear mass (MEM) were arr anged in a sheet-likearchitecture with small trabeculae projecting from most of th e lesion. Focally,th e cells had a slightl y larger nucleus tha n those from th e stapes margin , with euchromasia and a mod erate amount ofpink cytoplasm. Str om al tissue surro un ding the sem icircu lar bone formed gland lumina,which differed from the tr abecular patt ern seen elsewhere, and included two cell typ es, A and B (figur e 2). Type A (mucinous, luminal) cells were ob served to have atte nua ted, less-well-seen cytoplasm , while type B (neuroendo crine, basal) cells had more ample eosinophilic cyto plasm. Paraffin sections of th e MEM and stapes included cells th at were im m uno reactive with pancyto keratin, a marker express ed by all neopl astic cells. Immunohistoch emic ally, differential express ion of luminal cells with ma rkers CK7 and epithelial membrane antigen, and in particular, basal cell expression of chromogranin (figur e 3), further support find ings~~r e~o ns i s t e n t with NAME than the diagno sis of ceru m in ous ad enoma mad e previously at another institution .
Discussion NAME tumors occur in approxi ma tely equa l distr ibution in both sexes. Age at pr esent ation ran ges from 14 to 80 years,"with an average of approximately 37 years.' Patients present clinically with progressive unilateral conductive hearing loss, tinnitus, and a feeling of fullness or stuffiness in th e ear ; pain and vertigo m ayor may not be present.' Facial nerve involvement and bon y erosio n or destruction appea r to indicate a poor er pro gnosis." Radi ographic imaging reveals a soft-tissue den sity in the middl e ear th at may encase th e ossicles without destro ying th em . Because th ese tumors are relatively unc ommon, their clinical manifestations are often misread and attributed to other caus es.Differenti al diagn osis of such middle ear masses includes ceruminous adenoma, ceruminous adenocarcinoma, parotid pleomorphic aden oma , meningioma, paraglioma, and other abno rmalities. Adeno mas of th e middle ear were described first in 1976 by Derlacki an d Barney.' Th ey felt th e histologic appea rance of the tumors was most con sistent with an origin from colum nar or cuboidal epithelium, with limited nonmucous secretory activity.Previou s observation ofan incre ase in secretory cells-particularly mucinous cells and cells with dark , secretory gra nules-with occasional gland formation in cases of serous otitis m edia led to their hypothesis that these neoplasms ari se from middle ear epithelium .
In another study, Hyam s and Michaels proposed th at adenomas origina ted from the mucosal epithelium of th e middle ear,"Th eir hypothesis was derived from th eir perc eiving tumor cells in th e sur face epithelial layer and invasion of the underlying strom al layer.
The earliest paper mentioning neuroendocrine differentiation of the tumors, by Murphy et al in 1980, m ade th e ob servation that carcinoid tumors resem bled adenomatous tumors." The auth ors suggested tha t the ben ign appearance and biologic behavio r of m any reported adenomatous tumors of the middle ear might indicate unrecognized carcinoid differentiation. Fayemi and Toker also noted the sim ilarity in appearance between prim ary adenoca rcinoma of th e middle ear and carcinoid. 1 Clinically, mixed tumors are confined to the middle ear and mastoid; they rarely involve th e otic capsule or facial nerve, and they m ay be m isdiagno sed as chronic otitis media. In contrast, papill ary neoplasms extend into the petrous apex and may involve the po sterior and/ or middle cranial fossa and th e facial ne rve. Papill ary patterned tumors have been referred to as low-grade adenocarcinomas for their more invasive nature.' Surgical managem ent is the standard of care for middle ear m asses. En bloc resection, including involved parts of the ossicular chain , has been shown to effect clini cal cu re. Cases th at involved th e ossicles, but whose treatment did not include th eir removal, resulted in an 18 to 22% recurrence rate.?,13,14 Patients who underwent ENT·Ear, Nose & Throat Journal· April 2009 subsequent sur geries to completely remove remnants of remaining tumor had good clinic al outcomes. Radiation th erap y is not recommended for these tumors as their clinical ma nifestations are a result of mass effect and they have very little malignant potenti al."
Conclusion
A rare pathologic entity, the NAME can be differentiated from other tumors of the middle ear by histologic and immunohistoch emical features.Histologic analysis after th e surgical procedure will establish the diagnosis . The treatment of choice is complete surg ical resection without additional therapy. Altho ugh th ese are slowgrowing tumors with low metastatic poten tial,recurrence is possible. Th erefore, long-term follow-up is needed.
